Lantheus Holdings, Inc. (LNTH) stock
LNTHNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/3012% above fair value
$101.80+0.08 (+0.08%)
Close on Nov 17, 2026Market cap $6.64BP/E 24.6Yield –
Lantheus price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Lantheus's price to book ratio was 5.1× on Nov 11, 2026, against 3.8× a year earlier. Over the last 5 years it ranged from 3.2× to 13.5×, with a median of 6.0×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 5.1× | +0.8 |
| 2025 | Dec 31, 2025 | 4.3× | −1.1 |
| 2024 | Dec 31, 2024 | 5.4× | −0.8 |
| 2023 | Dec 29, 2023 | 6.2× | +0.7 |
| 2022 | Dec 30, 2022 | 5.5× | +1.6 |
| 2021 | Dec 31, 2021 | 3.9× | +2.2 |
| 2020 | Dec 31, 2020 | 1.8× | −6.2 |
| 2019 | Dec 31, 2019 | 8.0× | −2.9 |
| 2018 | Dec 31, 2018 | 10.8× | – |
See a number that looks wrong?